Posted By
Jo Huang
22-Jan-2024 15:21
Found In
Egroup:
Regulatory Open Forum
\
view thread
Dear Colleagues, It has been very challenging to deal with our NB since we submitted our MDR for class 3, AIMD. While under MDR review, NB has been asking that we submit every and all changes, regardless of significance made to the product. We've been receiving micro review requests on non-significant ...
|